efficacy of oral zinc therapy in epidermodysplasia verruciformis with squamous cell carcinoma
Clicks: 116
ID: 128757
2014
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.0
/100
116 views
31 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #40 of 63 articles by views in journal of nuclear cardiology
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Epidermodysplasia verruciformis (EV) is a rare, inherited disorder that predisposes patients to widespread human papillomavirus (HPV) infection and cutaneous squamous cell carcinomas. There is still no definitive therapeutic modality for EV. A 24 year old male patient with EV was treated with oral zinc sulphate, one of the cheapest and safe immuno-modulator available as therapeutic agent with satisfactory result.
| Reference Key |
sharma2014indianefficacy
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Sudhanshu Sharma;Krishna Deb Barman;Rashmi Sarkar;Mukesh Manjhi;Vijay Kumar Garg |
| Journal | journal of nuclear cardiology |
| Year | 2014 |
| DOI |
10.4103/2229-5178.126034
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.